89bio, Inc.
ETNB
$8.18
-$0.17-2.04%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -118.35M | -149.07M | -47.97M | -51.68M | -40.24M |
| Total Depreciation and Amortization | 9.00K | 8.00K | 12.00K | 9.00K | 16.00K |
| Total Amortization of Deferred Charges | 326.00K | 175.00K | 168.00K | 162.00K | 179.00K |
| Total Other Non-Cash Items | 3.34M | 4.35M | 2.87M | 2.35M | 2.32M |
| Change in Net Operating Assets | -6.90M | -822.00K | -16.25M | 9.44M | 3.43M |
| Cash from Operations | -121.58M | -145.36M | -61.16M | -39.72M | -34.29M |
| Capital Expenditure | -15.00K | -- | -- | -- | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.84M | -8.64M | 27.85M | -79.90M | -63.64M |
| Cash from Investing | 19.82M | -8.64M | 27.85M | -79.90M | -63.64M |
| Total Debt Issued | 0.00 | 9.35M | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 136.56M | 24.75M | 27.86M | 22.97M | 162.17M |
| Repurchase of Common Stock | -18.00K | -904.00K | -39.00K | -1.69M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -137.00K | 0.00 | 137.00K | -253.00K | -- |
| Cash from Financing | 136.41M | 33.19M | 27.96M | 21.03M | 162.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.65M | -120.81M | -5.36M | -98.59M | 64.24M |
